Skip to main content
Premium Trial:

Request an Annual Quote

Firm Helps Bioinformatics Companies Plan Strategies

Premium

MORAGA, Calif.--HighTech Business Decisions, a new company here devoted to helping electronics and biotechnology companies determine successful business development strategies, will focus on bioinformatics as one of its key markets, according to founder and president Sandra Fox. "Biotech nology markets are expanding into areas such as bioinformatics, high-throughput screening assays for new biopharmaceuticals, and scale-up manufacturing," she observed. "Contract manufacturing has become an important strategy. HighTech Business Decisions is in position to track these business-to-business markets as they evolve and help clients increase sales."

The new firm will match industry specialists who have PhD's or MBA's with clients in need of customized market research, Fox explained. HighTech has a web site at http://www.hitechbiz.com.

Filed under

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.